Global Oncology Market Gains Ground, Driven by Innovative Cancer Treatment Therapies
Survival rates for several major cancers have steadily improved over the last couple of decades, according to the American Cancer Society (ACS). Still, an annual report estimates there will be nearly 1.7 million new cancer cases in 2017, and close to 700,000 deaths from the disease in the United States. While early detection and the reduction of certain risk factors play a role in increased survival rates, so does the application of innovative therapies. TapImmune, Inc. (NASDAQ: TPIV) (TPIV Profile), Pfizer Inc. (NYSE: PFE), Celgene Corporation (NASDAQ: CELG), Bristol-Myers Squibb Company (NYSE: BMY) and Clovis Oncology, Inc. (NASDAQ: CLVS) are…







